Biotech Import/Export Controls

1. Introduction

Biotech import and export controls refer to the legal rules, regulatory procedures, licensing requirements, and monitoring mechanisms governing the international movement of biotechnology products, biological materials, genetically modified organisms (GMOs), microorganisms, genetic resources, vaccines, biological samples, and other biotechnology-related technologies.

These controls are designed to ensure that biological materials are transferred safely and lawfully between countries without creating risks to human health, animal health, biodiversity, national security, or environmental sustainability.

Biotechnology has become an important component of international trade because countries increasingly exchange vaccines, pharmaceutical products, genetically engineered seeds, laboratory microorganisms, biological research materials, and genetic technologies. However, these products may also create risks involving infectious diseases, biological weapons, unauthorized genetic-resource exploitation, and environmental contamination.

Therefore, biotech import/export controls seek to balance international scientific cooperation and commercial development with biosafety, biosecurity, intellectual property protection, and national sovereignty.

2. Objectives of Biotech Import/Export Controls

The principal objectives include:

1. Protection of Public Health: Preventing the unauthorized importation of infectious biological agents, contaminated samples, and unsafe biotechnology products.

2. Environmental Protection: Controlling the international movement of genetically modified organisms and other biological materials that may adversely affect biodiversity.

3. National Biosecurity: Preventing biological materials, equipment, and technologies from being diverted for harmful purposes.

4. Regulation of Genetic Resources: Ensuring that biological materials obtained from foreign countries are accessed and utilized according to applicable consent and benefit-sharing requirements.

5. Trade Compliance: Establishing transparent licensing, customs declarations, inspection, and documentation procedures.

6. Scientific Accountability: Ensuring that biotechnology companies, laboratories, universities, and research institutions comply with international safety standards.

3. International Legal Framework

A. Cartagena Protocol on Biosafety, 2000

The Cartagena Protocol is one of the most important international instruments governing the transboundary movement of living modified organisms (LMOs).

It establishes procedures for the safe transfer, handling, and use of LMOs resulting from modern biotechnology.

Its important provisions include:

Article 7: Advance Informed Agreement procedure for certain intentional transboundary movements.

Article 8: Notification requirements by the exporting party.

Article 10: Decision-making procedures for imports.

Article 18: Requirements concerning handling, transport, packaging, and identification.

The protocol recognizes that genetically modified organisms may create environmental risks and therefore requires appropriate risk assessment and regulatory oversight.

B. Convention on Biological Diversity, 1992

The Convention on Biological Diversity recognizes the sovereign rights of countries over their biological resources.

It establishes principles governing access to genetic resources, conservation of biodiversity, and equitable benefit-sharing.

These principles are relevant when biological materials are exported for pharmaceutical research, genetic engineering, agricultural biotechnology, and commercial product development.

C. Nagoya Protocol, 2010

The Nagoya Protocol establishes an international framework for access to genetic resources and benefit-sharing.

It requires appropriate prior informed consent and mutually agreed terms, where applicable under domestic access and benefit-sharing legislation.

It also encourages countries to monitor the utilization of genetic resources obtained from foreign jurisdictions.

D. Biological Weapons Convention, 1972

The Biological Weapons Convention prohibits the development, production, acquisition, and stockpiling of biological and toxin weapons.

It is relevant to biotechnology export controls because certain biological materials, equipment, and technologies may have both legitimate scientific and harmful applications.

E. World Trade Organization Framework

The WTO Agreement on the Application of Sanitary and Phytosanitary Measures (SPS Agreement) governs measures intended to protect human, animal, and plant health.

It requires relevant health and safety measures to be scientifically justified and not to constitute arbitrary discrimination or disguised restrictions on international trade.

The Technical Barriers to Trade (TBT) Agreement may also apply to biotechnology-related product standards, labelling, and technical regulations.

4. Indian Legal Framework Governing Biotech Import and Export

India regulates biotechnology imports and exports through environmental legislation, foreign trade regulations, customs laws, biodiversity legislation, and sector-specific guidelines.

A. Environment (Protection) Act, 1986

This Act provides the statutory foundation for regulating hazardous microorganisms and genetically engineered organisms.

The Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Micro-organisms/Genetically Engineered Organisms or Cells, 1989, were notified under this Act.

Rule 7 requires approval of the competent regulatory authority for specified activities involving hazardous microorganisms and genetically engineered organisms.

These rules cover:

Import and export of genetically engineered organisms.

Transportation and storage of hazardous microorganisms.

Commercial production of genetically engineered products.

Research involving genetically modified organisms.

Handling and disposal of potentially hazardous biological materials.

The principal regulatory authorities include the Genetic Engineering Appraisal Committee (GEAC) and Review Committee on Genetic Manipulation (RCGM). RCGM primarily monitors research-related safety, while GEAC performs important regulatory and approval functions, particularly for activities involving environmental release and specified large-scale applications.

IBKP+2

B. Foreign Trade (Development and Regulation) Act, 1992

This legislation empowers the Central Government to regulate international trade through import and export policies.

The Directorate General of Foreign Trade (DGFT) administers foreign trade controls and issues relevant authorizations.

Biotechnology-related products may be classified as freely importable, restricted, or prohibited depending on their nature and applicable policy conditions.

Importers and exporters must comply with applicable ITC (HS) classification requirements, licensing conditions, and regulatory approvals.

C. Customs Act, 1962

The Customs Act regulates the physical entry and exit of biological materials and biotechnology products.

Customs authorities may examine shipments, verify declarations, inspect documentation, and enforce applicable import and export restrictions.

Undeclared or unauthorized biological materials may result in detention, seizure, confiscation, penalties, or other legal consequences, depending on the applicable provisions.

D. Biological Diversity Act, 2002

This legislation is particularly important when imported or exported materials involve Indian biological resources or associated traditional knowledge.

It establishes requirements concerning access, authorization, and benefit-sharing, subject to statutory scope and exemptions.

The National Biodiversity Authority plays an important role in regulating access and associated commercial utilization.

E. Plant Quarantine (Regulation of Import into India) Order, 2003

This Order regulates the import of plants, seeds, planting materials, and other regulated agricultural articles.

It establishes phytosanitary requirements intended to prevent the introduction of foreign pests, diseases, and harmful organisms into India.

Imported plant materials may require import permits, phytosanitary certificates, inspection, and quarantine treatment.

F. Human Biological Samples and Research Materials

India also regulates the international transfer of human biological samples, including blood, tissue, and other specimens.

Requirements differ depending on whether samples are transferred for biomedical research, diagnostics, or commercial purposes. Applicable institutional approvals, government permissions, and documentation must be considered.

IBKP+3

5. Export Controls on Dual-Use Biotechnology

Certain biotechnology materials and equipment may have both legitimate scientific applications and potential military or harmful applications.

India regulates specified dual-use items through the Special Chemicals, Organisms, Materials, Equipment and Technologies (SCOMET) framework under its foreign trade policy.

Depending on the classification, export may require authorization from DGFT.

Controlled categories can include specified biological agents, toxins, genetic elements, related equipment, and biotechnology technologies.

Exporters may be required to:

Identify the relevant SCOMET classification.

Verify the end-user and intended end-use.

Obtain necessary export authorization.

Maintain shipment and transaction records.

Comply with applicable sanctions and international obligations.

These controls are important for preventing the diversion of biotechnology materials into prohibited biological weapons programmes.

6. Import and Export Compliance Requirements

A biotechnology organization generally needs to consider the following compliance stages:

Product Classification: Determine whether the material is a GMO, hazardous microorganism, pharmaceutical, biological sample, agricultural product, or controlled dual-use item.

Regulatory Authorization: Obtain approvals from the relevant authorities before shipment.

Safety Assessment: Conduct appropriate biosafety, environmental, and health-risk assessments.

Documentation: Maintain invoices, permits, certificates, material-transfer agreements, and shipment declarations.

Packaging and Transportation: Follow applicable biological safety, labelling, containment, and transport standards.

Customs Clearance: Submit accurate declarations and supporting documents.

Post-Import Monitoring: Ensure that the material is used only for its approved purpose.

7. Important Judicial Decisions and Case Laws

A. Gene Campaign v. Union of India (2024), 2024 INSC 545

The Supreme Court examined the regulatory approval of genetically modified mustard (DMH-11) and the legal framework governing genetically modified crops.

The case raised questions concerning environmental safety, regulatory transparency, scientific assessment, and the precautionary principle.

The Court agreed that decisions of regulatory authorities concerning GMOs are subject to judicial review. It also directed the Union Government to formulate a national policy on GM crops covering research, cultivation, trade, and commerce.

The Court further emphasized compliance with Section 23 of the Food Safety and Standards Act, 2006, concerning packaging and labelling of imported GM food, particularly GM edible oil.

Legal significance: This judgment directly establishes the importance of regulatory scrutiny, transparency, and food-safety compliance in biotechnology imports and trade.

Sci API+1

B. Aruna Rodrigues v. Union of India (2012)

The Supreme Court considered concerns regarding the environmental release of genetically modified organisms without adequate biosafety assessment.

The petitioners challenged the regulatory framework governing GMO imports, manufacture, research, and environmental release.

The proceedings highlighted the need for independent scientific evaluation, proper biosafety protocols, and effective regulatory supervision.

Legal significance: The case reinforces the importance of precautionary regulation and scientific accountability when biological materials are imported or introduced into the environment.

Indian Kanoon

C. Monsanto Technology LLC v. Nuziveedu Seeds Ltd. (2019) 3 SCC 381

The Supreme Court examined patent rights concerning Monsanto's Bt cotton technology and disputes relating to genetically modified seeds.

The Court recognized that the technical and scientific issues surrounding the patent dispute required appropriate adjudication and expert examination.

Legal significance: The judgment demonstrates the importance of intellectual property protection, biotechnology commercialization, and the legal regulation of genetically modified agricultural technologies.

Sci API

8. Major Legal Challenges

Biotech import/export controls face several significant challenges:

1. Regulatory differences: Countries follow different standards for approving GMOs and biological products, creating difficulties for international trade.

2. Biosecurity risks: Biological materials may be diverted from legitimate research towards harmful purposes.

3. Unintentional contamination: Improper packaging and transportation may cause accidental environmental exposure.

4. Intellectual property disputes: International biotechnology transactions may involve disputes concerning patents, licensing, and ownership of genetic technologies.

5. Traditional knowledge exploitation: Biological resources may be commercially utilized without appropriate authorization or benefit-sharing.

6. Customs enforcement: Identifying genetically modified or hazardous biological materials can require specialized scientific testing and technical expertise.

9. Suggestions for Strengthening Legal Controls

Governments should establish harmonized international standards for biotechnology shipments, strengthen customs inspection systems, and improve cooperation between environmental and trade regulators.

Biotechnology exporters should adopt transparent end-user verification, risk assessment, and shipment-monitoring procedures.

India should further strengthen coordination among DGFT, Customs, GEAC, RCGM, the National Biodiversity Authority, and plant quarantine authorities.

Special attention should also be given to emerging technologies, including synthetic biology, gene editing, engineered microorganisms, and AI-designed biological products.

10. Conclusion

Biotech import/export controls are essential for ensuring the safe and responsible international movement of biological materials and biotechnology products. International instruments such as the Cartagena Protocol, Convention on Biological Diversity, Nagoya Protocol, and Biological Weapons Convention provide important regulatory foundations.

In India, the Environment (Protection) Act, 1986, the 1989 Rules, Foreign Trade (Development and Regulation) Act, 1992, Customs Act, 1962, and Biological Diversity Act, 2002 collectively establish important mechanisms for controlling biotechnology-related international trade.

Judicial decisions such as Gene Campaign v. Union of India, Aruna Rodrigues v. Union of India, and Monsanto Technology LLC v. Nuziveedu Seeds Ltd. demonstrate the importance of environmental protection, scientific accountability, and responsible biotechnology commercialization.

Ultimately, an effective biotech import/export control system must facilitate legitimate scientific cooperation and international trade while preventing biological hazards, unauthorized exploitation of genetic resources, environmental damage, and misuse of sensitive biotechnology.